Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| CS640 | C21H31N7O | 2388506-83-8 | Details |
| Thalidomide-NH-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2460022-53-9 | Details |
| NS2B/NS3-IN-3 hydrochloride | C19H21N3O2.ClH | 2832876-91-0 | Details |
| Smurf1-IN-1 | C24H29ClN6O2 | 1824708-03-3 | Details |
| Yhhu6669 | C29H28ClFN6O3 | 2569526-80-1 | Details |
| BRD4 Inhibitor-28 | C23H21N3O3 | 2468960-80-5 | Details |
| NLRP3-IN-21 | C20H13Cl2F3N6O2S | 2956791-61-8 | Details |
| RDR 02308 | C19H15N3O3 | 4155-82-2 | Details |
| SLC26A3-IN-3 | C20H17IO5 | 2369983-43-5 | Details |
| MuRF1-IN-2 | C23H22N2O7 | 937891-74-2 | Details |
| Z-LLF-CHO | C29H39N3O5 | 133429-58-0 | Details |
| TWIK-1/TREK-1-IN-2 | C20H29F3N2O2 | 1440532-32-0 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| HPK1-IN-35 | C30H32N8O3S | 2935903-77-6 | Details |
| AMX12006 | C26H22F3N3O3 | 2639775-01-0 | Details |
| BChE/HDAC6-IN-1 | C34H43N5O5 | 2925457-27-6 | Details |
| AJH-836 | C22H38O5 | 388621-67-8 | Details |
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| 84-B10 | C25H22F3NO5 | 698346-43-9 | Details |
| Dihydromyristicin | C11H14O3 | 52811-28-6 | Details |
| Erythronic acid | C4H8O5 | 13752-84-6 | Details |
| OPC-163493 | C14H8F3N5S | 1644467-84-4 | Details |
| Ledipasvir hydrochloride | C49H55ClF2N8O6 | 2128695-48-5 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| BODIPY FL thalidomide | C37H43BF2N6O7 | 2740620-18-0 | Details |
| Antitubercular agent-36 | 2883173-82-6 | Details |
| NLRP3-IN-17 | C21H22N4O2S | 2254432-75-0 | Details |
| Antileishmanial agent-14 | 1638956-72-5 | Details |
| Nrf2 activator-7 | 2456295-39-7 | Details |
| EGFR-IN-82 | C32H41BrN9O2P | 2568086-81-5 | Details |
| SIRT5 inhibitor 7 | C28H32ClN7O3S | 2951090-00-7 | Details |
| MC-VA-PAB-Exatecan | C50H54FN7O11 | 2680543-57-9 | Details |
| Xilmenolone | C26H37N3O2 | 2368807-26-3 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| Anticancer agent 110 | C18H13FN6OS | 887349-03-3 | Details |
| Dihydro-5-azacytidine acetate | 2470972-18-8 | Details |
| Neuraminidase-IN-13 | 2222067-23-2 | Details |
| ZINC475239213 | C21H15N5O2 | 2871002-89-8 | Details |
| SIKs-IN-1 | C27H31F2N7O | 2927557-06-8 | Details |
| Asp-Asp-Asp-Asp-Asp-Asp | C24H32N6O19 | 145224-96-0 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| EGFR-IN-85 | C26H30N8O2 | 1956378-29-2 | Details |
| Brazilein | C16H12O5 | 600-76-0 | Details |
| CYP11A1-IN-1 | C27H34N2O5 | 2744168-51-0 | Details |
| SHP2-IN-13 | C16H21N7O | 2951854-02-5 | Details |
| SIRT5 inhibitor 6 | C21H28N6O4S | 2834736-82-0 | Details |
| EP12 | C26H22FN3O2 | 2882916-73-4 | Details |
| MAO-B-IN-23 | C19H18BrNO | 2107978-22-1 | Details |
| HIV-1 inhibitor-57 | C25H24FN5O3S | 2745197-24-2 | Details |
| Antimalarial agent 19 | 2897630-89-4 | Details |
| SJ1461 | C21H18ClN7OS2 | 2924546-70-1 | Details |
| Keap1-Nrf2-IN-15 | 2456295-45-5 | Details |
| J-1048 | C23H17FN6S2 | 2374772-60-6 | Details |
| YIAD-0205 | C26H16Br2ClN3 | 2446054-34-6 | Details |
| MMP13-IN-4 | C21H17BrN4O5 | 514855-02-8 | Details |
| U-89843A | C16H24ClN5 | 157013-85-9 | Details |
| PDE7-IN-3 | C18H21ClN2O4 | 908570-13-8 | Details |
| α-Synuclein inhibitor 9 | C27H24O4 | 1510825-03-2 | Details |
| E235 | C28H25FN4OS | 891894-69-2 | Details |
| TH-Z835 | C30H38N6O | 2766209-50-9 | Details |
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 | C30H58N10O12 | 2244602-35-3 | Details |
| Ac-Exatecan | C26H24FN3O5 | 2922852-48-8 | Details |
| LTB4 antagonist 2 | C26H23NO6 | 2929239-85-8 | Details |
| SARS-CoV-2 nsp14-IN-3 | C17H17N3O3S | 2920574-16-7 | Details |
| DNA gyrase B-IN-3 | C14H9Cl2N3O4S | 2412834-56-9 | Details |
| TWIK-1/TREK-1-IN-1 | C21H24F3NO3 | 1440532-30-8 | Details |
| CDK/HDAC-IN-3 | C24H18Cl2N6O3 | 2944087-54-9 | Details |
| LL-37, Human TFA | C???H???N??O??.C?HF?O? | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| Pomalidomide-5-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2863635-00-9 | Details |
| Lepzacitinib | C18H21N5O3 | 2321488-47-3 | Details |
| Anticancer agent 164 | C21H23F3N8O2S2 | 2235393-30-1 | Details |
| Dim16 | C29H38IN5 | 2743448-32-8 | Details |
| Aurora Kinases-IN-4 | C26H28N8O | 2877011-84-0 | Details |
| BC-05 | C21H29BN2O9 | 2260717-73-3 | Details |
| LSD1-UM-109 | C29H27FN6 | 2252446-26-5 | Details |
| M62812 free base | C13H11N3OS | 613262-61-6 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| JNJ-1013 | C46H55N9O7S | 2597343-08-1 | Details |
| S07-1066 | C16H11Cl2FO2 | 876625-29-5 | Details |
| IDO1-IN-21 | 2892432-98-1 | Details |
| IL-1β-IN-2 | 2242896-76-8 | Details |
| MY-673 | C18H14N2O4 | 2944459-96-3 | Details |
| HDAC-IN-63 | C25H26Cl2N6O3 | 2920046-95-1 | Details |
| Cholesterol nervonate | C51H90O2 | 60758-73-8 | Details |
| Eledoisin Related Peptide 2TFA | C34H58N8O6S | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| SHP2-IN-5 | C12H8O6 | 54755-93-0 | Details |
| Aβ/tau aggregation-IN-3 | C23H22N4O3 | 1210750-32-5 | Details |
| RET-IN-22 | C29H31F3N6O4 | 2918281-79-3 | Details |
| LTB4 antagonist 3 | C29H27NO6 | 2929239-87-0 | Details |
| hnNOS-IN-2 | C18H23F2N3 | 2700326-00-5 | Details |
| MmpL3-IN-3 | C26H33ClN2Si | 1639438-67-7 | Details |
| Chitin synthase inhibitor 14 | C25H26ClN5O5 | 2922114-19-8 | Details |
| CK2-IN-9 | C23H29N9O | 1461658-58-1 | Details |
| TFLLR-NH2 2TFA(197794-83-5(free base)) | C31H53N9O6 | Details |
| A-77636 | C20H27NO3 | 778546-51-3 | Details |
| Demethylcantharidate disodium | C8H11NaO5 | 129-67-9 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | ||||